GDLSK

products

UPDATE: USTR ANNOUNCES ADDITIONAL EXCLUSIONS GRANTED ON SEC. 301 LIST 4 PRODUCTS

On March 25, 2020, the U.S. Trade Representative (“USTR”) announced that 12 items will be excluded from the Section 301 trade remedies imposed on Chinese-origin products.   The newly announced exclusions all relate to items on China 301 List 4A (which is part of the $300 billion trade action) which, unless excluded, are currently subject to […]

USTR SOLICITING COMMENTS ON THE REMOVAL OF CHINA SEC. 301 DUTIES FROM ADDITIONAL MEDICAL-CARE PRODUCTS

In a March 23, 2020 notice, the Office of the United States Trade Representative (“USTR”) has solicited comments identifying additional medical-care items that should be excluded from China Section 301 tariffs in light of the ongoing COVID-19 outbreak. The comment period will remain open at least until June 25, 2020 (subject to potential extensions as […]

UPDATE: USTR ANNOUNCES ADDITIONAL EXCLUSIONS GRANTED / MODIFICATIONS ON SEC. 301 LIST 3 PRODUCTS

On March 20, 2020, the U.S. Trade Representative (“USTR”) announced that 182 items will be excluded from the Section 301 trade remedies imposed on Chinese-origin products. In addition the scope of two existing exclusions is being modified.  The newly announced exclusions / modifications all relate to items on China 301 List 3 (which is part […]

UPDATE: USTR ANNOUNCES ITS FIRST EXCLUSIONS GRANTED TO SEC. 301 LIST 4A PRODUCTS

On March 12, 2020, the U.S. Trade Representative (“USTR”) announced two new groups of exclusions from the Section 301 trade remedies imposed on Chinese-origin products.

UPDATE: USTR ANNOUNCES ADDITIONAL EXCLUSIONS GRANTED TO SEC. 301 LIST 3 PRODUCTS

On December 31, 2019, the U.S. Trade Representative (“USTR”) announced that 68 additional HTS provisions and product descriptions will be excluded from the Section 301 trade remedies imposed on Chinese-origin products. The newly announced exclusions all relate to items on China 301 List 3 (the $200 billion trade action) which, unless excluded, are subject to […]

UPDATE: W.T.O. DECISION AUTHORIZES THE U.S. TO IMPOSE $7.5 BILLION IN TARIFFS ON E.U. PRODUCTS

On October 2, 2019, the World Trade Organization (“W.T.O.”) announced that the U.S. can impose $7.5 billion in tariffs annually on products of the European Union (“E.U.”), in retaliation for the E.U. illegally subsidizing its large civil aircraft manufacturer, Airbus. In anticipation of this decision, the U.S. prepared two lists of tariff provisions on which […]

UPDATE: USTR ANNOUNCES ADDITIONAL EXCLUSIONS GRANTED TO SEC. 301, TRANCHES 1 & 2 PRODUCTS

On September 27, 2019, the U.S. Trade Representative (“USTR”) announced that 203 additional product descriptions will be excluded from the Section 301 trade remedies imposed on Chinese-origin products. The 203 exclusions consist of 92 product descriptions from Tranche 1 and 111 product descriptions from Tranche 2. This latest set supplements the exclusions the USTR previously […]

UPDATE: USTR ANNOUNCES ADDITIONAL EXCLUSIONS GRANTED TO SEC. 301, TRANCHE 1 PRODUCTS

On September 17, 2019, the U.S. Trade Representative (“USTR”) announced that 310 additional product descriptions will be excluded from Sec. 301, Tranche 1; this latest set supplements the six earlier set of exclusions the USTR granted to Tranche 1 products. The list of 310 newly-excluded product descriptions is provided below. The exclusions will be retroactive […]

UPDATE: USTR ADDS TO LIST OF EU PRODUCTS BEING CONSIDERED FOR SEC. 301 TARIFFS

On July 2, 2019, the U.S. Trade Representative (“USTR”) announced that additional products of the European Union (“EU”) are being considered for inclusion in the list of products that may be subject to additional, Sec. 301, tariffs of up to 100%. The list of 89 additional tariff subheadings are valued at approximately $4 billion in […]

UPDATE: USTR ISSUES PROPOSED LIST 4 EXTENDING SEC. 301 TARIFFS TO “ESSENTIALLY ALL” REMAINING CHINESE IMPORTS

On May 13, 2019, the U.S. Trade Representative (“USTR”) issued a proposed List 4 which threatens to impose additional tariffs of up to 25% on “essentially all” Chinese products imported into the U.S. that were not covered by previous section 301 pronouncements. Pharmaceuticals, certain chemicals made into prescription pharmaceuticals, rare earth minerals and critical minerals […]